Whole-exome sequencing explored mechanism of selpercatinib resistance in RET-rearranged lung adenocarcinoma transformation into small-cell lung cancer: a case report

被引:5
作者
Yan, Peng [1 ]
Zhu, Zheng [2 ]
Zewen, Wang [1 ]
Liu, Yanan [1 ]
Zhang, Mingyan [3 ]
Sun, Meili [1 ]
机构
[1] Shandong First Med Univ, Cent Hosp Affiliated, Oncol Dept, Jinan, Peoples R China
[2] PLA Rocket Force Characterist Med Ctr, Res Dept, Beijing, Peoples R China
[3] Shandong Univ, Sch Med, Jinan, Peoples R China
关键词
NSCLC; RET-rearranged; Whole-exome sequencing; Small cell transformation; MUTATIONAL PROCESSES; CARCINOMAS;
D O I
10.1186/s12890-023-02799-5
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Small cell transformation was one mechanism by which EGFR-mutation NSCLC acquired resistance after tyrosine kinase inhibitors (TKIs) treatment. A few reports of small cell transformation occurred in other oncogene-driven lung cancers. We found the first case of transformation of a RET-rearranged lung adenocarcinoma to SCLC after selpercatinib, a novel highly selective RET TKIs. Whole-exome sequencing (WES) was used to explore alteration in gene expression in tumor tissue at initial diagnosis and after transformation into small cell carcinoma. We found that transformed into SCLC tumor tissue had inactivation of RB1 and TP53, with RET fusion was still present. In addition, the APOBEC family of cytidine deaminases appeared amplification. Although RET rearrangement still existed, using another RET TKIs was ineffective, and etoposide plus platinum might be an effective rescue treatment.
引用
收藏
页数:9
相关论文
共 19 条
[11]   Mechanisms of resistance to selective RET tyrosine kinase inhibitors in RET fusion-positive non-small-cell lung cancer [J].
Lin, J. J. ;
Liu, S., V ;
McCoach, C. E. ;
Zhu, V. W. ;
Tan, A. C. ;
Yoda, S. ;
Peterson, J. ;
Do, A. ;
Prutisto-Chang, K. ;
Dagogo-Jack, I ;
Sequist, L., V ;
Wirth, L. J. ;
Lennerz, J. K. ;
Hata, A. N. ;
Mino-Kenudson, M. ;
Nardi, V ;
Ou, S-H, I ;
Tan, D. S-W ;
Gainor, J. F. .
ANNALS OF ONCOLOGY, 2020, 31 (12) :1725-1733
[12]   Small cell transformation of ROS1 fusion-positive lung cancer resistant to ROS1 inhibition [J].
Lin, Jessica J. ;
Langenbucher, Adam ;
Gupta, Pranav ;
Yoda, Satoshi ;
Fetter, Isobel J. ;
Rooney, Marguerite ;
Do, Andrew ;
Kem, Marina ;
Chang, Kylie Prutisto ;
Oh, Audris Y. ;
Chin, Emily ;
Juric, Dejan ;
Corcoran, Ryan B. ;
Dagogo-Jack, Ibiayi ;
Gainor, Justin F. ;
Stone, James R. ;
Lennerz, Jochen K. ;
Lawrence, Michael S. ;
Hata, Aaron N. ;
Mino-Kenudson, Mari ;
Shaw, Alice T. .
NPJ PRECISION ONCOLOGY, 2020, 4 (01)
[13]   EGFR-Mutant Adenocarcinomas That Transform to Small-Cell Lung Cancer and Other Neuroendocrine Carcinomas: Clinical Outcomes [J].
Marcoux, Nicolas ;
Gettinger, Scott N. ;
O'Kane, Grainne ;
Arbour, Kathryn C. ;
Neal, Joel W. ;
Husain, Hatim ;
Evans, Tracey L. ;
Brahmer, Julie R. ;
Muzikansky, Alona ;
Bonomi, Philip D. ;
del Prete, Salvatore ;
Wurtz, Anna ;
Farago, Anna F. ;
Dias-Santagata, Dora ;
Mino-Kenudson, Mari ;
Reckamp, Karen L. ;
Yu, Helena A. ;
Wakelee, Heather A. ;
Shepherd, Frances A. ;
Piotrowska, Zofia ;
Sequist, Lecia V. .
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04) :278-+
[14]   Mutational Processes Molding the Genomes of 21 Breast Cancers [J].
Nik-Zainal, Serena ;
Alexandrov, Ludmil B. ;
Wedge, David C. ;
Van Loo, Peter ;
Greenman, Christopher D. ;
Raine, Keiran ;
Jones, David ;
Hinton, Jonathan ;
Marshall, John ;
Stebbings, Lucy A. ;
Menzies, Andrew ;
Martin, Sancha ;
Leung, Kenric ;
Chen, Lina ;
Leroy, Catherine ;
Ramakrishna, Manasa ;
Rance, Richard ;
Lau, King Wai ;
Mudie, Laura J. ;
Varela, Ignacio ;
McBride, David J. ;
Bignell, Graham R. ;
Cooke, Susanna L. ;
Shlien, Adam ;
Gamble, John ;
Whitmore, Ian ;
Maddison, Mark ;
Tarpey, Patrick S. ;
Davies, Helen R. ;
Papaemmanuil, Elli ;
Stephens, Philip J. ;
McLaren, Stuart ;
Butler, Adam P. ;
Teague, Jon W. ;
Jonsson, Goran ;
Garber, Judy E. ;
Silver, Daniel ;
Miron, Penelope ;
Fatima, Aquila ;
Boyault, Sandrine ;
Langerod, Anita ;
Tutt, Andrew ;
Martens, John W. M. ;
Aparicio, Samuel A. J. R. ;
Borg, Ake ;
Salomon, Anne Vincent ;
Thomas, Gilles ;
Borresen-Dale, Anne-Lise ;
Richardson, Andrea L. ;
Neuberger, Michael S. .
CELL, 2012, 149 (05) :979-993
[15]   Concurrent RB1 and TP53 Alterations Define a Subset of EGFR-Mutant Lung Cancers at risk for Histologic Transformation and Inferior Clinical Outcomes [J].
Offin, Michael ;
Chan, Joseph M. ;
Tenet, Megan ;
Rizvi, Hira A. ;
Shen, Ronglai ;
Riely, Gregory J. ;
Rekhtman, Natasha ;
Daneshbod, Yahya ;
Quintanal-Villalonga, Alvaro ;
Penson, Alexander ;
Hellmann, Matthew D. ;
Arcila, Maria E. ;
Ladanyi, Marc ;
Pe'er, Dana ;
Kris, Mark G. ;
Rudin, Charles M. ;
Yu, Helena A. .
JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) :1784-1793
[16]   An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers [J].
Roberts, Steven A. ;
Lawrence, Michael S. ;
Klimczak, Leszek J. ;
Grimm, Sara A. ;
Fargo, David ;
Stojanov, Petar ;
Kiezun, Adam ;
Kryukov, Gregory V. ;
Carter, Scott L. ;
Saksena, Gordon ;
Harris, Shawn ;
Shah, Ruchir R. ;
Resnick, Michael A. ;
Getz, Gad ;
Gordenin, Dmitry A. .
NATURE GENETICS, 2013, 45 (09) :970-+
[17]   Understanding Lineage Plasticity as a Path to Targeted Therapy Failure in EGFR-Mutant Non-small Cell Lung Cancer [J].
Shaurova, Tatiana ;
Zhang, Letian ;
Goodrich, David W. ;
Hershberger, Pamela A. .
FRONTIERS IN GENETICS, 2020, 11
[18]   Cell of Origin of Small Cell Lung Cancer: Inactivation of Trp53 and Rb1 in Distinct Cell Types of Adult Mouse Lung [J].
Sutherland, Kate D. ;
Proost, Natalie ;
Brouns, Inge ;
Adriaensen, Dirk ;
Song, Ji-Ying ;
Berns, Anton .
CANCER CELL, 2011, 19 (06) :754-764
[19]   RET Fusions Define a Unique Molecular and Clinicopathologic Subtype of Non-Small-Cell Lung Cancer [J].
Wang, Rui ;
Hu, Haichuan ;
Pan, Yunjian ;
Li, Yuan ;
Ye, Ting ;
Li, Chenguang ;
Luo, Xiaoyang ;
Wang, Lei ;
Li, Hang ;
Zhang, Yang ;
Li, Fei ;
Lu, Yongming ;
Lu, Qiong ;
Xu, Jie ;
Garfield, David ;
Shen, Lei ;
Ji, Hongbin ;
Pao, William ;
Sun, Yihua ;
Chen, Haiquan .
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (35) :4352-4359